🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🐭 Calling all mouse model researchers! 🐭 Apply now for Alamar’s Mouse Grant Program 🔬 120+ protein targets 🧠 Inflammation, neurodegeneration, and cancer 📉 Detect low-abundance biomarkers with high sensitivity ⏳ Due: May 16, 2025 👉 ow.ly/8NJp50VnsSR #Proteomics

🧠 Experience pTau and Beyond at #ADPD2025! 📅 Product Theater: Thursday, April 3 | 10:40–11:10 AM 🧾12 posters with NULISA data 👋 Booth #22C: Demo the ARGO HT System ow.ly/ktvs50VoYQM #Neurodegeneration #Biomarkers #Alzheimers #Parkinsons #Proteomics #NULISA #ARGOHT

🧠 Advancing Biomarker Discovery in #Neurodegeneration with MULTIPLEX analysis using Dried Blood & Plasma Spots 🔍 See poster No. 607 at #ADPD2025, April 4-5, where we evaluated 120 neurodegenerative and inflammatory proteins across multiple microsampling formats with #NULISA.

🌍 On this #WorldHealthDay, we’re celebrating the power of science to transform human health. Alamar’s #NULISA technology is advancing precision #proteomics with ultra-sensitive biomarker detection—uncovering disease earlier than ever. Learn more 👉 ow.ly/xU3M50VvVrK

🌍 This #EarthDay2025, we celebrate the power of science to protect human health and the planet. By advancing earlier disease detection, we're helping build a healthier, more sustainable future. Learn more: alamarbio.com #InnovatingForHealth #OurPowerOurPlanet

🧬🔬 Webinar: Identifying Predictive Biomarkers of irAEs with #NULISAseq Join experts from MD Anderson Cancer Center and Alamar Biosciences, as they share new research on non-invasive biomarker discovery in #CAR-T & ICI therapies. Register today👉 ow.ly/yVzx50VGFiq

Visit us at #BNA2025 at booth S9 to learn more about how high-sensitivity, multiplex protein biomarker detection from biofluids is advancing #neurodegenerative disease research. ow.ly/CrUT50VJ6JF

🚨 Excited to be a part of the 4th ALS Drug Development Summit in Boston! Join Dr. Christopher Bunker from Alamar Biosciences, tomorrow at 9 am, as he presents on #NULISA —a breakthrough platform for ultra-sensitive, high-plex #ALS biomarker detection. 👉 alamarbio.com/4th-als-drug-d…

We just expanded the NULISAseq™ CNS Disease Panel 120—now featuring the first blood-based assays for brain-derived pTau217, pTau181, pTau231, and total tau (tTau). Learn more: ow.ly/qWtc50VSY5c #Proteomics #Neurodegeneration #Biomarkers #Tau #AlzheimersResearch #NULISAseq

🧠 We’re proud to sponsor the 8th Venusberg Meeting on Neuroinflammation and present how ultrasensitive, brain-specific protein biomarkers are transforming neuroscience research. Learn More: ow.ly/7kcr50VTzl8

Alamar Biosciences is proud to sponsor and exhibit at the Inaugural Neurology Symposium "The Role of Inflammation in Neurological Disease Manifestations " at Universitätsklinikum Freiburg on May 24, 2025 🧠 #Neuroinflammation #Neuroimmunology #MSResearch #Proteomics #Biomarkers

In a recent publication led by Dr. Nicholas Ashton (Banner Health & University of Gothenburg), researchers tapped into the power of NULISA™ to uncover novel plasma biomarkers tied to #Alzheimer’s and other #neurodegenerative diseases. ow.ly/Zbp150VYPu8 #proteomics

💪A powerful new partnership in proteomics! We are proud to announce a strategic collaboration with @SciLifeLab to advance the frontiers of translational proteomics. 🔬 Learn more: ow.ly/A6IT50VZKfM #Proteomics #Biomarkers #PrecisionMedicine #EarlyDetection

We are proud to be a Gold Sponsor of this year’s CIBERNED International Conference on Neuroinflammation, Aging and Neurodegeneration. Don’t miss our featured talk showcasing #NULISA. Learn more: ow.ly/kRry50VZKlw #Neurodegeneration #Biomarkers #Proteomics #CIBERNED2025

🚨 Major move in #Alzheimers research: Alamar, @ADDI_AD & Gates Ventures are launching a global effort to profile 40K+ plasma samples using ultra-sensitive #proteomics to drive earlier detection & new biomarkers. Follow us to stay informed. 🔬🧠 #biomarkers #NULISA

We’re a Diamond Sponsor #FENS2025, June 16–19 in Oslo! Stop by to see how our ultra-sensitive, high-plex proteomics platform supports biomarker discovery in brain health from just microliters of sample ow.ly/fNrK50W5zkw #Neuroscience #Biomarkers #Proteomics

📍 We’re heading to Saint-Malo next week for #EuPA2025! Join Alamar Biosciences at Europe’s leading proteomics conference, June 16–20. Let’s talk biomarkers, biofluids, and breakthroughs. 👋 See you there! ow.ly/QRJQ50W5zqA #Biomarkers #Proteomics #NULISA

Thrilling day at the #TDP43 Summit in Wisconsin! 15 speakers, 50+ attendees, and hundreds online sharing TDP43 data. Thanks to UW–Madison, Allyn Rose, and @EnigmaBiomedical! Learn more: ow.ly/TiiW50W8EFP #proteomics #NULISA #proteinbiomarkers

🧠 Don’t miss our #FENS2025 workshop ft. Andréa Lessa Benedet , Univ. of Gothenburg on advancing biofluid biomarker discovery. 📅 June 16 | 🕘 09:45 | Vilhelm Bjerknes’ hus, Aud 4 See how precision proteomics is pushing brain health research forward. #Neuroscience #Biomarkers

🚨 Live Tomorrow! Join experts Prof. David Sharp & Dr. Cheryl Wellington for a webinar on how #NULISAseq high-sensitivity, multiplexed assays are uncovering blood-based biomarkers to transform #TBI research. 🔗 Register: ow.ly/ClLj50W11pC #Neurotrauma #Proteomics #NULISA